A convergent, versatile route to two synthetic conjugate anti-toxin malaria vaccines.
The synthesis of two glycosylphosphatidyl inositol (GPI) glycans that constitute the malaria toxin and promising anti-toxin vaccine constructs using a scalable route is described.